I'm going to ask my colleague to fill in a little, but just to be clear, yes, what I was referring to is the period during which Health Canada will review a drug for authorization in Canada and when it will conclude that review.
Then what I was trying to refer to as well is that there are other processes that typically take place before a product will be available at, say, a pharmacy. That includes a review, which we call the health technology assessment, by CADTH—or INESSS in Quebec—and then there will be perhaps some negotiation on pricing.
However, my colleague can fill in those other steps as well, if the chair permits.